Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Journal
Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
pubmed:
8
2
2019
medline:
8
2
2019
entrez:
8
2
2019
Statut:
ppublish
Résumé
The HTML version of this Article contained errors in Supplementary Figure S2 "Flowchart of the lyso-Gb3 screening and gene analysis in female patients", which have been detailed in the associated Correction.
Identifiants
pubmed: 30728527
doi: 10.1038/s41436-019-0447-8
pii: S1098-3600(21)01495-7
pmc: PMC7609257
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
1263Commentaires et corrections
Type : ErratumFor